Suzanne Bird

Director/Board Member at BIOREGENX, INC.

Net worth: 13 312 $ as of 2024-05-30

59 year

Consumer Services

Health Technology

Suzanne Bird active positions

Companies	Position	Start	End
BIOREGENX, INC.	Director/Board Member	2024-03-07	-

Companies	Position	Start	End
BioRegenx, Inc. BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023.	Director/Board Member	-	-

Southern Adventist University

Undergraduate Degree

International

United States	3
	2

Operational

Director/Board Member	2
Undergraduate Degree	1

Sectoral

Consumer Services	2
Health Technology	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	2
Findit, Inc.
BioRegenx, Inc. BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023.	Health Technology

Private companies

Findit, Inc.

Health Technology